Life Sciences - Official Partner Bringing Proven R&D Innovation to Japan

Delivering proven life sciences R&D solutions from leading international innovators as their official partner in Japan.

We act as the trusted bridge, enabling Japanese companies to access global best-in-class platforms with confidence.

France/USA

A solution that accelerates drug discovery and clinical development for cancer and other hard-to-treat diseases by applying AI and federated learning to multimodal analysis of clinical, pathological, and molecular data, including spatial transcriptomics.

  • Building disease prediction models integrating clinical, pathological, and molecular data
  • Enabling precision medicine through patient stratification
  • Optimizing clinical trial design and patient recruitment strategies
  • Creating novel therapeutic approaches using spatial transcriptomics

Belgium

An early-stage life sciences intelligence platform that integrates global R&D data — publications, patents, funding, clinical trials — and uses AI to identify research collaborators, map competitive activity, and uncover new research opportunities.

  • Finding collaborators among researchers, institutions, and companies
  • Visualizing competitive research and technology trends
  • Identifying new R&D opportunities and potential partners
  • Unified search and analysis of publications, patents, and grants

UK

A data curation platform that uses AI, large language models (LLM), and NLP to integrate knowledge from publications, patents, and clinical trials, building knowledge graphs with Galactic AI™ to support target discovery and biomedical insights.

  • Discovering novel therapeutic targets and biomarkers
  • Analyzing drug mechanisms of action and disease pathways
  • Structuring knowledge through knowledge graph creation
  • Improving efficiency in research reviews and information retrieval

USA

An AI-powered decision support solution that quantifies risk in clinical development and predicts probability of technical and regulatory success (PTRS) for drug and clinical programs with high accuracy.

  • Increasing decision-making confidence with explainable AI
  • Reducing risk through PTRS prediction and visualization for development programs
  • Accelerating development by optimizing trial design and phase transitions
  • Supporting portfolio strategy with asset comparisons and benchmarking

Spain

A bioinformatics platform delivering omics analysis — including RNA-seq and metagenomics — through both SaaS and custom solutions.

  • Cloud-based bioinformatics analysis (RNA-seq, genomics, metagenomics, and more)
  • Real-time omics analysis via SaaS tools (AIR / GAIA / GINO)
  • Custom software development and bioinformatics consulting
  • Microbiome analysis decision support via the MICK platform for clinical applications